Strowitzki T, Korell M, Seehaus D, Hepp H
Department of Obstetrics and Gynaecology, Klinikum Grosshadern, University of Munich, Germany.
Hum Reprod. 1993 Oct;8(10):1703-7. doi: 10.1093/oxfordjournals.humrep.a137918.
Transvaginal gamete intra-Fallopian transfer (GIFT) is a new treatment modality for patients with proven tubal patency, avoiding invasive laparoscopy. In this study 79 cycles of standard laparoscopic GIFT (group 1) were analysed in comparison to 40 cycles of transvaginal intratubal gamete transfer guided by tactile sensation (group 2). GIFT in group 1 was performed for standard indications; patients with severe intra-abdominal adhesions, distal tubal pathology, peritubal adhesions or extreme obesity were included in group 2. No difference in mean age, duration of infertility, oestradiol level and number of oocytes was found. In group 1 a clinical pregnancy rate of 33% per GIFT cycle (n = 79) was achieved. The clinical pregnancy rate in group 2 was 17.5% per gamete transfer cycle. In conclusion, transvaginal GIFT offers an acceptable chance for in-vivo fertilization to patients who cannot be treated laparoscopically despite having patent tubes and who refuse in-vitro fertilization.
经阴道配子输卵管内移植(GIFT)是一种针对输卵管通畅已得到证实的患者的新治疗方式,可避免进行侵入性腹腔镜检查。在本研究中,对79个标准腹腔镜GIFT周期(第1组)进行了分析,并与40个通过触觉引导的经阴道输卵管内配子移植周期(第2组)进行了比较。第1组的GIFT按照标准适应症进行;第2组纳入了有严重腹腔内粘连、输卵管远端病变、输卵管周围粘连或极度肥胖的患者。在平均年龄、不孕持续时间、雌二醇水平和卵母细胞数量方面未发现差异。第1组每个GIFT周期(n = 79)的临床妊娠率为33%。第2组每个配子移植周期的临床妊娠率为17.5%。总之,经阴道GIFT为尽管输卵管通畅但无法接受腹腔镜治疗且拒绝体外受精的患者提供了一个可接受的体内受精机会。